Cargando…
Elevated Adenylyl Cyclase 9 Expression Is a Potential Prognostic Biomarker for Patients with Colon Cancer
BACKGROUND: Adenylyl cyclase 9 (ADCY9) is an enzyme that modulates signal transduction by producing the second messenger, cyclic adenosine monophosphate (cAMP). The aim of the present study was to investigate the association of ADCY9 expression with clinicopathological features and disease-free surv...
Autores principales: | Yi, Hua, Wang, Kun, Jin, Jun-feng, Jin, He, Yang, Lihua, Zou, Yidan, Du, Biaoyan, Liu, Xiaodong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5759510/ https://www.ncbi.nlm.nih.gov/pubmed/29292367 http://dx.doi.org/10.12659/MSM.906002 |
Ejemplares similares
-
Overexpression of Rho-Associated Coiled-Coil Containing Protein Kinase 2 Is Correlated with Clinical Progression and Poor Prognosis in Breast Cancer
por: Yi, Hua, et al.
Publicado: (2018) -
The Prognostic Value of m6A RNA Methylation Regulators in Colon Adenocarcinoma
por: Liu, Tao, et al.
Publicado: (2019) -
Effects and Mechanism of Imatinib in Inhibiting Colon Cancer Cell Proliferation
por: Samei, Lv, et al.
Publicado: (2016) -
Identification of Critical Genes and Five Prognostic Biomarkers Associated with Colorectal Cancer
por: Huang, Zuoliang, et al.
Publicado: (2018) -
CBX8 and CD96 Are Important Prognostic Biomarkers of Colorectal Cancer
por: Song, Xin, et al.
Publicado: (2018)